ClinicalTrials.Veeva

Menu

Nd:YAG Laser Hyaloidotomy for Premacular Hemorrhage in Diabetic Eyes

T

Tanta University

Status

Completed

Conditions

Proliferative Diabetic Retinopathy

Treatments

Procedure: Nd:YAG laser Hyaloidotomy

Study type

Interventional

Funder types

Other

Identifiers

NCT04285151
TUOR002

Details and patient eligibility

About

Premacular Subhyaloid hemorrhage is a sudden profound loss of vision in eyes with proliferative diabetic retinopathy (PDR). Pars plana vitrectomy is the treatment of choice for premacular hemorrhage in eyes with proliferative changes. Nd:YAG laser hyaloidotomy has been used to evacuate the premacular hemorrhage

Enrollment

25 patients

Sex

All

Ages

21 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Eyes with premacular subhyaloid hemorrhage of more than 3 disc diameters, involving the fovea.
  • Eyes with proliferative diabetic retinopathy

Exclusion criteria

  • Dense media opacity (corneal/cataract)
  • Patients with bleeding tendency or on anti-coagulant drugs

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems